1. Entrepreneurial Best Practices Series
“SECRETS TO THE SUCCESSFUL BUSINESS PITCH: A VC PERSPECTIVE”
Date: Tuesday, March 3, 2009
Time: 6:30-8:30pm
Venue: Wells Fargo Room, Haas School of Business, UC Berkeley
De Novo Ventures will lead a session designed to illustrate what is required to make a successful pitch to venture capitalists.
The audience will be asked to participate as potential investors - evaluating a potential deal as a founder pitches his idea in a real time, role-play scenario. This will be based on an actual medical technology proposal. The session is designed to be highly interactive and will allow you to ask questions about what really goes on as venture capitalists listen to a pitch. You will discover what the hidden agendas are in the questions they routinely ask of first time founders and their teams. We promise you will come away with a different perspective on venture capitalists, and a better understanding of how to deal with the process before, during and after the pitch.
FEATURED SPEAKERS:
David M. Mauney, M.D. is one of the co-founders of De Novo. Prior to co-founding De Novo, David was a Partner at Asset Management Company, where he worked with Pitch Johnson as the lead partner in healthcare investments. At AMC, he led seed and early stage investments in TriVascular (acquired by Boston Scientific), Novare Surgical Systems (licensed to Johnson & Johnson), Enteric Medical Technologies (acquired by Boston Scientific), and participated in seven financings of technology companies. David was the first employee and Director of Business Development for Fox Hollow Technologies (Nasdaq: EVVV) and worked in product management for Heartport (acquired by Johnson & Johnson). He earned his MD degree from The Dartmouth School of Medicine and a BA from Duke University.
David sits on the boards of Articulinx, Applied Spine, ProMed, Simpirica, TRIA Beauty, VeinRx and Ventus Medical. He also represented De Novo on investments in CyroVascular, Lumend and Paracor Medical.
Jay Watkins is a Managing Director at De Novo Ventures. Prior to joining De Novo in 2002, Jay was a co-founder of Origin Medsystems, a venture-funded medical technology start-up that was purchased by Eli Lilly & Company in 1992. When Eli Lilly divested its medical device businesses to form Guidant in 1995, he became a member of the corporation’s management committee, serving in this role from 1995-2002. During this time, he served as president of numerous divisions, including the Minimally Invasive Surgery Group. In addition, Jay was the President of Compass, Guidant Corporation’s corporate business development and new ventures group. Prior to founding Origin, Jay held management positions in several start-ups, including Microgenics Corporation, and was a consultant with the international consulting firm of McKinsey & Company. He has been a member of the board of directors of several public companies, including Gynecare, Cardiogenesis, and Rita Medical. Jay received his MBA from Harvard University and his undergraduate degree from Stanford University.
Jay sits on the boards of EBR Systems, PhotoThera, Pulmonx, Sierra Surgical, Synergeyes and Ventus Medical. He also represented De Novo on investments in Lumend and Hansen Medical.
Zachary Edmonds began his academic career at Pomona College, majoring in neuroscience. He went on to complete joint MD/MBA degrees (emphasis in entrepreneurship) at the UCLA School of Medicine and Anderson School of Management. During business school he interned at Guidant Corporation studying pricing strategy in the medtech industry. Through this experience he developed a profound interest in device-based diagnostics and therapeutics. Zachary moved on to residency in Internal Medicine at Stanford University Medical Center. Upon completion of his residency, he obtained formal training as an innovator in the Stanford Biodesign Fellowship. Out of that experience he co-founded and launched a start-up medical device venture (Niveus Medical) focused on rehabilitation of critically ill patients.
Zachary currently works as a hospitalist for the Palo Alto Medical Foundation, with appointments at El Camino Hospital and Stanford University Medical Center. In addition, he consults for De Novo Ventures on a part-time basis.
The Entrepreneurial Best Practices Series brings to UC Berkeley and the Haas School of Business the best practitioners from the Berkeley and Silicon Valley community to speak about the practical aspects of entrepreneurial activity. The program will start with food and networking at 6:30. The presentation will open at 7:00pm. There is no pre-registration for this event. For more information about the Entrepreneurial Best Practices Series, call 510-642-4255 or email lester@haas.berkeley.edu.